Latest Earnings Results: Q2 '26
Estimated EPS
-$0.10
Reported EPS
-$0.05
Surprise
+52.38%
Estimated Rev
$9.5M
Reported Rev
$12M
Surprise
+26.35%
• Reported GAAP EPS of -$0.05 up 91.23% YoY • Reported revenue of $12M up 32.92% YoY
Bullish Takeaway
Biofrontera delivered strong financial results with 33% revenue growth, significant gross margin expansion, and a $5.0 million improvement in Adjusted EBITDA compared to the second quarter of the prior year.
Bearish Takeaway
Biofrontera faces operational risks from an International Trade Commission exclusion order on its lamp product, while continuing to report net losses and a reduction in cash and cash equivalents.
Generated by Stocktwits using AI and company-reported earnings data for Q2 '26. This recap is intended to help readers understand the quarter quickly. Verify key figures in the linked source materials; the summary may contain errors and is not investment advice.
Historical Earnings
Quarterly
Annual
EPS
Revenue
| Fiscal Period | Estimated | Reported | Surprise | Result |
|---|---|---|---|---|
Q3 '26 | -$0.22 | -- | -- | N/A |
Q2 '26 | -$0.10 | -$0.05 | 52.38% | BEAT |
Q1 '26 | -$0.12 | -$0.41 | -256.52% | MISSED |
Q4 '25 | $0.19 | -- | -- | N/A |
Q3 '25 | -$0.58 | -$0.62 | -6.90% | MISSED |